Frank Cichocki

13PUBLICATIONS
101CO-AUTHORS
Innate immunityHaematological tumoursMolecular targetsGenetic immunologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Feb 27, 2026
Integrated Single-Cell Profiling Reveals Dichotomous NK Cell Populations Associated with Immunosuppression in Solid Tumors.

John R Lozada, Atef Ali, Christine Luo

|Aug 26, 2025
Chronic NK cell activation results in a dysfunctional, tissue resident-like state mediated by KLF2 deficiency.

Jacob A Myers, Rih-Sheng Huang, Shee Kwan Phung

|Jan 28, 2025
Expression Patterns of DLL3 across Neuroendocrine and Non-neuroendocrine Neoplasms Reveal Broad Opportunities for Therapeutic Targeting.

John R Lozada, Andrew Elliott, Mark G Evans

|Jul 02, 2024
High-dimensional single-cell analysis of human natural killer cell heterogeneity.

Lucas Rebuffet, Janine E Melsen, Bertrand Escalière

|Jul 19, 2023
Nicotinamide enhances natural killer cell function and yields remissions in patients with non-Hodgkin lymphoma.

Frank Cichocki, Bin Zhang, Cheng-Ying Wu

|Jun 21, 2023
NK Cells from Human Cytomegalovirus-Seropositive Individuals Have a Distinct Metabolic Profile That Correlates with Elevated mTOR Signaling.

John R Lozada, Bin Zhang, Jeffrey S Miller

Pageof 3

Frequent Collaborators

8 joint publications

Jeffrey S Miller

4 joint publications

Bin Zhang

4 joint publications

John R Lozada

4 joint publications

Justin Hwang